Canopy Growth

(NYSE: CGC)
Healthcare  |  Drug Manufacturers - Specialty & Generic
24.89 -0.26 -1.03%
Stock Price | Aug. 23, 2019, 3:59 p.m.
11 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 25.15
52 Week Low: 24.39
52 Week High: 59.25
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more Read less

Recently Viewed Tickers

Premium Weekly Review 08/23/19

9 hours ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/23/19

22 Comments
16 hours ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/23/19

37 Comments
Yesterday

Premium Cannabis Stocks Review - Weekend Edition 08/19/19

17 Comments
5 days ago

Premium Weekly Review 08/16/19

2 Comments
6 days ago

Premium Cannabis Stocks Review - AM Edition 08/16/19

334 Comments
1 week ago

Premium Instead of a Pre-Market Video 8/16/19

9 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 08/15/19

445 Comments
1 week ago

Premium Instead of a Pre- Market Video 8/14/19

2 Comments
1 week ago

Premium This Metric Suggests Valuations on Many Canadian LPs Are Reasonable

5 Comments
1 week ago